ea0034p170 | Neoplasia, cancer and late effects | SFEBES2014
Gururaj Sowmya
, Cartwright Victoria
, Mostafa Samiul
, Hunter Ann
, Gleeson Helena
Background: Bone marrow transplant (BMT) survivors are at increased risk of metabolic syndrome and developing type 2 diabetes (T2DM). Measurement of HbA1c is increasingly used in recent years for the diagnosis of T2DM. An HbA1c level of ≥6.5% (48 mmol/mol) is considered as a diagnostic cut-off for T2DM and an HbA1c between 6.06.4% (4247 mmol/mol) is considered as at risk of T2DM. We aimed to look at the diagnostic performance of HbA1c and oral glucose toleran...